Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
United Therapeutics
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participated in United Therapeutics Study TDE-PH-310
All women of childbearing potential (WOCBP) must have practiced true abstinence from intercourse when it was in line with their preferred and usual lifestyle or used 2 different forms of highly effective contraception for the duration of the study and for at least 30 days after discontinuing study medication.
Males who participated in the study must have used a condom during the length of the study and for at least 48 hours after their last dose of study medication.
You may not be if
The subject was pregnant or lactating.
The subject had received infused or inhaled prostacyclin therapy for 29 days or more.
The subject was prematurely discontinued from TDE-PH-310 for reasons other than a clinical worsening event.
The subject developed a concurrent illness or condition during the conduct of TDE-PH-310 which, in the opinion of the Investigator, would represent a risk to their overall health if they enrolled in this study.
